Newspaper Publication of Annual Audited Financial Results for the Quarter and Year ended March 31, 2026
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma has published its audited financial results for Q4 and full year ended March 31, 2026 in Business Line and Nava Telangana newspapers on May 30, 2026. This filing complies with SEBI Listing Regulation 47, which requires listed companies to publish quarterly and annual financial results in newspapers. The actual financial figures are contained in a separate outcome document (OutcomeofBM29052026.pdf) linked to the filing. The company trades on BSE (scrip code 524816) and NSE (scrip code NATCOPHARM).
This is a routine regulatory compliance filing confirming that annual financial results have been publicly disclosed. The actual impact on the stock will depend on the numbers disclosed in the detailed financial results document, not this notification itself.